Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

Press releases published on October 5, 2026

9 hours ago

Sofwave to Participate in the Jefferies Private MedTech Virtual Summit

Indeterminate GlobeNewswire

9 hours ago

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

Indeterminate GlobeNewswire

9 hours ago

vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)

Indeterminate GlobeNewswire

9 hours ago

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom

Indeterminate GlobeNewswire

9 hours ago

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Indeterminate GlobeNewswire

9 hours ago

Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study

Indeterminate GlobeNewswire

9 hours ago

Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

9 hours ago

AID FOR AIDS and AID FOR LIFE to Celebrate 30 Years of Global Humanitarian Impact at My Hero Gala in New York

Indeterminate GlobeNewswire

9 hours ago

Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical

Indeterminate GlobeNewswire

10 hours ago

Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform

Indeterminate GlobeNewswire

10 hours ago

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

Indeterminate GlobeNewswire

10 hours ago

BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels

Indeterminate GlobeNewswire

10 hours ago

Vireo Growth Inc. Announces Financing for New York and Florida Cultivation Facility

Indeterminate GlobeNewswire

10 hours ago

FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026

Indeterminate GlobeNewswire

10 hours ago

Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold

Indeterminate GlobeNewswire

10 hours ago

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

10 hours ago

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

10 hours ago

Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026

Indeterminate GlobeNewswire

10 hours ago

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

Indeterminate GlobeNewswire

10 hours ago

Satellos Granted Composition of Matter Patent for Forazapadin

Indeterminate GlobeNewswire